Recently, the R&D team of Daoqun Pharmaceutical rushed to Liaoning Haiyi Pharmaceutical Co., Ltd. to follow up on the shipment of the first batch of Jinqi Jiangtang capsules commissioned for production.

After a series of active preparations, new breakthroughs have been made in the production and operation of Jinqi hypoglycemic capsules. With the joint efforts of departments such as production, quality, warehousing, and logistics enterprises, the first batch of Jinqi hypoglycemic capsules was successfully released from the warehouse in June and officially shipped to various parts of the country.

The successful delivery and launch of the first batch of Jinqi hypoglycemic capsules will bring strong confidence and motivation to the subsequent sales, and also bring good news to the majority of diabetes patients.

关于金芪降糖胶囊

▼▼▼▼▼

·The first traditional Chinese patent medicines and simple preparations that can improve insulin resistance through the glucose clamp test!

·Originating from a famous formula, developed by the Chinese Academy of Sciences, with numerous evidence-based research papers published both domestically and internationally!

·National basic medicine, medical insurance class B, recommended drugs in diabetes guidelines, hypoglycemic and lipid-lowering, and joint efficiency enhancement!